Zhihui Huang, Koo Han Yoo, Duohui Li, Qingxin Yu, Luxia Ye, Wuran Wei
{"title":"Pan-cancer analysis of m1A writer gene RRP8: implications for immune infiltration and prognosis in human cancers","authors":"Zhihui Huang, Koo Han Yoo, Duohui Li, Qingxin Yu, Luxia Ye, Wuran Wei","doi":"10.1007/s12672-024-01299-0","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Ribosomal RNA Processing 8 (RRP8) is a gene associated with RNA modification and has been implicated in the development of several types of tumors in recent research. Nevertheless, the biological importance of RRP8 in pan-cancer has not yet been thoroughly and comprehensively investigated.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>In this study, we conducted an analysis of various public databases to investigate the biological functions of RRP8. Our analysis included examining its correlation with pan-cancer prognosis, heterogeneity, stemness, immune checkpoint genes, and immune cell infiltration. Furthermore, we utilized the GDSC and CTRP databases to assess the sensitivity of RRP8 to small molecule drugs.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Our findings indicate that RRP8 exhibits differential expression between tumor and normal samples, particularly impacting the prognosis of various cancers such as Adrenocortical carcinoma (ACC) and Kidney Chromophobe (KICH). The expression of RRP8 is intricately linked to tumor heterogeneity and stemness markers. Additionally, RRP8 shows a positive correlation with the presence of tumor-infiltrating cells, with TP53 being the predominant mutated gene in these malignancies.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Our findings suggest that RRP8 may serve as a potential prognostic marker and therapeutic target in a variety of cancer types.</p>","PeriodicalId":13170,"journal":{"name":"Hormones and Cancer","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormones and Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12672-024-01299-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Ribosomal RNA Processing 8 (RRP8) is a gene associated with RNA modification and has been implicated in the development of several types of tumors in recent research. Nevertheless, the biological importance of RRP8 in pan-cancer has not yet been thoroughly and comprehensively investigated.
Methods
In this study, we conducted an analysis of various public databases to investigate the biological functions of RRP8. Our analysis included examining its correlation with pan-cancer prognosis, heterogeneity, stemness, immune checkpoint genes, and immune cell infiltration. Furthermore, we utilized the GDSC and CTRP databases to assess the sensitivity of RRP8 to small molecule drugs.
Results
Our findings indicate that RRP8 exhibits differential expression between tumor and normal samples, particularly impacting the prognosis of various cancers such as Adrenocortical carcinoma (ACC) and Kidney Chromophobe (KICH). The expression of RRP8 is intricately linked to tumor heterogeneity and stemness markers. Additionally, RRP8 shows a positive correlation with the presence of tumor-infiltrating cells, with TP53 being the predominant mutated gene in these malignancies.
Conclusion
Our findings suggest that RRP8 may serve as a potential prognostic marker and therapeutic target in a variety of cancer types.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
